Familial hypercholesterolemia affects the way the body processes cholesterol. As a result, people with familial hypercholesterolemia have a higher risk of heart disease and a greater risk of early heart attack.
The gene that causes familial hypercholesterolemia is inherited. The condition is present from birth. Treatments including medications and healthy lifestyle behaviors can help reduce the risks.
High cholesterol is a common medical condition, but it's often the result of unhealthy lifestyle choices, and thus preventable and treatable. With familial hypercholesterolemia, a person's risk of high cholesterol is higher because a defect (mutation) in a gene changes how the body processes cholesterol. This mutation prevents the body from removing low-density lipoprotein (LDL) cholesterol, the "bad" cholesterol, from the blood. As a result, plaques can cause your arteries to narrow and harden, increasing the risk of heart disease. Genetic testing can reveal whether you have this mutation.
These gene mutations are passed from parent to child. To have the condition, children need to inherit an altered copy of the gene from one parent. Most people with familial hypercholesterolemia have one affected gene and one normal gene. In rare cases, a person inherits an affected copy from both parents, which can lead to a more severe form of the condition.
Nov. 17, 2017
- Learning about familial hypercholesterolemia. National Human Genome Research Institute. http://www.genome.gov. Accessed Jan. 27, 2016.
- Familial hypercholesterolemia. MedlinePlus. https://www.nlm.nih.gov/medlineplus. Accessed Feb. 3, 2016.
- Hartgers ML, et al. New approaches in detection and treatment of familial hypercholesterolemia. Current Cardiology Reports. 2015:17:109.
- Pagon RA, et al., eds. Familial hypercholesterolemia. In: GeneReviews. Seattle, Wash.: University of Seattle, Washington; 1993-2016. http://www.ncbi.nlm.nih.gov/books/NBK1116. Accessed Jan. 6, 2016.
- National Library of Medicine. Hypercholesterolemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/hypercholesterolemia. Accessed Jan. 6, 2016.
- Integrated guidelines for cardiovascular health and risk reduction in children and adolescents. Bethesda, Md.: National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm. Accessed Dec. 7, 2015.
- Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov. Accessed Jan. 5, 2016.
- Rosenson RS, et al. Inherited disorders of LDL-cholesterol metabolism. http://www.uptodate.com/home. Accessed Jan. 6, 2016.
- Robinson JG. Management of familial hypercholesterolemia: A review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of Managed Care Pharmacy. 2013;19:139. http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=16222. Accessed Feb. 15, 2016.
- Dyslipidemia in children: Management. http://www.uptodate.com/home. Accessed Jan. 15, 2016.
- Goldman L, et al., eds. Disorders of lipid metabolism. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed Jan. 13, 2016.
- Drug therapy for cholesterol. American Heart Association. http://www.heart.org/HEARTORG/Conditions/Cholesterol/PreventionTreatmentofHighCholesterol/Drug-Therapy-for-Cholesterol_UCM_305632_Article.jsp#.Vpkg59hIiic. Accessed Jan. 15, 2016.